Hyperglycemia-induced cathepsin L maturation: Linking to diabetic comorbidities and COVID-19 mortality
ABSTRACT Diabetes, a prevalent chronic condition, significantly increases the risk of mortality from COVID-19, yet the underlying mechanisms remain elusive. Emerging evidence implicates Cathepsin L (CTSL) in diabetic complications, including nephropathy and retinopathy. Our previous research identified CTSL as a pivotal protease promoting SARS-CoV-2 infection. Here, we demonstrate elevated blood CTSL levels in individuals with diabetes, facilitating SARS-CoV-2 infection. Chronic hyperglycemia correlates positively with CTSL concentration and activity in diabetic patients, while acute hyperglycemia augments CTSL activity in healthy individuals.In vitrostudies reveal high glucose, but not insulin, promotes SARS-CoV-2 infection in wild-type cells, withCTSLknockout cells displaying reduced susceptibility. Utilizing lung tissue samples from diabetic and non-diabetic patients, alongside db/db diabetic and control mice, we illustrate increased CTSL activity in both humans and mice under diabetic conditions. Mechanistically, high glucose levels promote CTSL maturation and translocation from the endoplasmic reticulum to the lysosome via the ER-Golgi-lysosome axis. Our findings underscore the pivotal role of hyperglycemia-induced CTSL maturation in diabetic comorbidities and complications..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 06. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
He, Qiong [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.10.15.23297013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI04121059X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI04121059X | ||
| 003 | DE-627 | ||
| 005 | 20240307101437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231017s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.10.15.23297013 |2 doi | |
| 035 | |a (DE-627)XBI04121059X | ||
| 035 | |a (biorXiv)10.1101/2023.10.15.23297013 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a He, Qiong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hyperglycemia-induced cathepsin L maturation: Linking to diabetic comorbidities and COVID-19 mortality |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Diabetes, a prevalent chronic condition, significantly increases the risk of mortality from COVID-19, yet the underlying mechanisms remain elusive. Emerging evidence implicates Cathepsin L (CTSL) in diabetic complications, including nephropathy and retinopathy. Our previous research identified CTSL as a pivotal protease promoting SARS-CoV-2 infection. Here, we demonstrate elevated blood CTSL levels in individuals with diabetes, facilitating SARS-CoV-2 infection. Chronic hyperglycemia correlates positively with CTSL concentration and activity in diabetic patients, while acute hyperglycemia augments CTSL activity in healthy individuals.In vitrostudies reveal high glucose, but not insulin, promotes SARS-CoV-2 infection in wild-type cells, withCTSLknockout cells displaying reduced susceptibility. Utilizing lung tissue samples from diabetic and non-diabetic patients, alongside db/db diabetic and control mice, we illustrate increased CTSL activity in both humans and mice under diabetic conditions. Mechanistically, high glucose levels promote CTSL maturation and translocation from the endoplasmic reticulum to the lysosome via the ER-Golgi-lysosome axis. Our findings underscore the pivotal role of hyperglycemia-induced CTSL maturation in diabetic comorbidities and complications. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Zhao, Miao-Miao |4 aut | |
| 700 | 1 | |a Li, Ming-Jia |4 aut | |
| 700 | 1 | |a Li, Xiao-Ya |4 aut | |
| 700 | 1 | |a Jin, Jian-Min |4 aut | |
| 700 | 1 | |a Feng, Ying-Mei |4 aut | |
| 700 | 1 | |a Zhang, Li |4 aut | |
| 700 | 1 | |a Huang, Wei-Jin |4 aut | |
| 700 | 1 | |a Yang, Fang-Yuan |4 aut | |
| 700 | 1 | |a Yang, Jin-Kui |0 (orcid)0000-0002-5430-2149 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 06. März |
| 773 | 1 | 8 | |g year:2024 |g day:06 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.10.15.23297013 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 06 |c 03 | ||